Baxton Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.92 M
as on 17-11-2024
- Revenue -20.03%
(FY 2023)
- Profit -27.40%
(FY 2023)
- Ebitda 61.99%
(FY 2023)
- Net Worth 6.74%
(FY 2023)
- Total Assets 1.40%
(FY 2023)
About Baxton Pharmacia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.92 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kamaljit Singh and Shobhana serve as directors at the Company.
- CIN/LLPIN
U24232CH2012PTC033455
- Company No.
033455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Baxton Pharmacia Private Limited offer?
Baxton Pharmacia Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs, Anti Infective Agent, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Baxton Pharmacia?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamaljit Singh  | Director | 03-Jan-2012 | Current |
| Shobhana | Director | 12-Mar-2013 | Current |
Financial Performance of Baxton Pharmacia.
Baxton Pharmacia Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.03% decrease. The company also saw a substantial fall in profitability, with a 27.4% decrease in profit. The company's net worth moved up by a moderate rise of 6.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baxton Pharmacia?
In 2023, Baxton Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biomax Biotechnics Private LimitedActive 15 years 4 monthsKamaljit Singh and Shobhana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Dec 2015 | ₹0.92 M | Satisfied |
Axis Bank Limited Creation Date: 21 Feb 2014 | ₹5.00 M | Satisfied |
How Many Employees Work at Baxton Pharmacia?
Unlock and access historical data on people associated with Baxton Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baxton Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baxton Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
